SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nodality, Inc., which is focused on solving drug development challenges, announced today the launch of its PathPro™ product line. PathPro products leverage the unique capabilities of Nodality’s proprietary Single Cell Network Profiling (SCNP) technology, offering predefined multiparametric flow cytometry-based experimental panels. These panels allow us to study customer inhibitor activity and identify disease subgroups and differential responses in pathways or diseases. Nodality has introduced its first three PathPro products – the PathPro™ JAK-STAT panel, PathPro™ TLR and the PathPro™ AML panels – and these will be followed by additional products throughout 2015.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
